Breaking News on Pharmaceutical Technology |
Institut Rosell is the Human Health and Nutrition Division of the Canadian-based Lallemand Group. A pioneer in probiotic applications since 1934, Institut Rosell’s mission is to study, develop and produce probiotic solutions to help maintain and restore people’s health and well-being.
Today, Institut Rosell concentrates its research efforts on the scientific and clinical documentation of its probiotics strains and formulations developed for their health benefits, including gastrointestinal, the immune system, women’s health and children’s health. Thanks to branch offices in Europe, North America and Asia, these products are distributed worldwide, either under Institut Rosell’s own trademark, or via major players within the food supplement and pharmaceutical industries focused on consumer healthcare.
Global capabilities :
Americas, contact : Jacques Milette Tel : +1 514 858 4655 Fax : +1 514 383 4493
Asia, contact : Yong Zhou Tel: +86 10 6410 9325 Fax: +86 10 6410 9340
Europe, contact: Valérie Delahaye Tel:+33 5 62 74 55 55 Fax:+33 5 62 74 55 00
Access Institut Rosell-Lallemand Web site(s)
http://www.institut-rosell.com
Major Products :
Documented probiotic strains (Lactobacillus Rosell-52/ Lactobacillus Rosell-11, Bifidobacterium Rosell-175)
Probiocap™ microencaspulated bacteria
Stomach Acid Resistance Technology
Fermalac® vaginal
Probio’StickTM
ProBacti
ProbiokidTM
ProDefense
Lacidofil®
Lalflor
Protecflor®
S.boulardii
L.plantarum 299v
ProFlora
LalminTM : yeast rich in minerals
06-Jun-2008 - Institut Rosell-Lallemand and Lal'Food has added a fourth strain to its range of encapsulated probiotics as it looks to expand the range of functional foods, supplements and pharmaceutical applications into which it can be formulated.
17-Dec-2007 - Institut Rosell-Lallemand has teamed up with Ranbaxy and Aristo Pharmaceuticals to distribute supplements based on a probiotic bacteria, which will see it become available in the massive Indian market for Irritable Bowel Syndrome.
28-Nov-2007 - Institut Rosell-Lallemand will enter the Chilean market with a product based on its well-documented probiotic strain lp299v through a partnership with Merck.
25-Oct-2007 - Dietary supplements based on the Lactobacillus plantarum 299v probiotic by Institut Rosell-Lallemand have expanded further into Europe - a move which shows the increasing popularity of the friendly bacteria.
15-Oct-2007 - A probiotic formulation aimed at managing intestinal disorders has been launched by Institut Rosell-Lallemand, a move which reinforces probiotics' potential in cutting diarrhoea.